Trial Profile
A Single-Center Phase I Clinical Study to Evaluate The Biodistribution and Safety of 99mTC-Etarfolatide (EC20) in Normal Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Aug 2014
Price :
$35
*
At a glance
- Drugs Technetium Tc99m etarfolatide (Primary)
- Indications Inflammation; Non-small cell lung cancer; Ovarian cancer
- Focus Pharmacokinetics
- Sponsors Endocyte
- 01 Aug 2014 New trial record